Triptorelin
From Wikipedia, the free encyclopedia
Triptorelin
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | 57773-63-4 |
ATC code | L02AE04 |
PubChem | ? |
Chemical data | |
Formula | C64H82N18O13 |
Mol. weight | 1311.5 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
D |
Legal status |
℞-only |
Routes | Implant |
Triptorelin (acetate or palmoate) is a gonadotropin releasing hormone agonist (GnRH agonist). By causing constant stimulation of the pituitary, it decreases pituitary secretion of gonadotropins luteinizing hormone (LH) and follicle stimulating hormone (FSH). Like other GnRH agonists, triptorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer or breast cancer, precocious puberty, estrogen-dependent conditions (such as endometriosis or uterine fibroids), and in assisted reproduction. Triptorelin is marketed under the brand names Decapeptyl and Gonapeptyl.
[edit] References
- Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. J Pediatr Endocrinol Metab. 2000 Jul;13 Suppl 1:723-37. Review. PMID 10969915